Please refer the Attachment
Awaiting price reaction for this filing.
Medinova Diagnostic Services has fixed Tuesday, 25 November 2025 as the record date to identify eligible shareholders for receiving shares in Vijaya Diagnostic Centre Limited under a scheme of arrangement. Under the swap ratio, shareholders of Medinova will receive 1 equity share of Vijaya Diagnostic (face value INR 1) for every 22 equity shares held in Medinova (face value INR 10). This means Medinova shareholders will become shareholders of the listed Vijaya Diagnostic Centre. The intimation is being made under Regulation 42 of SEBI Listing Regulations, following a board meeting held on 3 November 2025.
Eligible Medinova shareholders as of 25 November 2025 will receive Vijaya Diagnostic shares in exchange for their Medinova holdings. This is a value-creating event for shareholders as they get exposure to the larger, listed Vijaya Diagnostic Centre at a defined swap ratio, though the effective value depends on Vijaya Diagnostic's prevailing market price.